Day One Biopharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $33,908 | $30,761 | $29,208 | $93,761 |
Gross Profit | 30,143 | 27,877 | 26,226 | 92,171 |
EBITDA | -34,974 | -40,173 | -64,573 | 29,636 |
EBIT | -35,938 | -41,067 | -65,332 | 28,890 |
Net Income | -30,322 | -35,996 | -65,714 | 37,037 |
Net Change In Cash | 33,908 | 30,761 | 29,208 | 93,761 |
Free Cash Flow | -21,309 | -62,814 | -31,427 | -4,971 |
Cash | 35,622 | 33,358 | 124,968 | 422,765 |
Basic Shares | 103,069 | 102,710 | 93,623 | 96,937 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $131,161 | $0 | $0 | $0 |
Gross Profit | 125,882 | -383 | -531 | -199 |
EBITDA | -217,270 | -206,064 | -146,378 | -72,544 |
EBIT | -219,299 | -206,447 | -146,909 | -72,743 |
Net Income | -95,496 | -188,917 | -132,176 | -70,442 |
Net Change In Cash | 131,161 | 0 | 0 | 0 |
Cost of Revenue | -199,047 | 240,581 | ||
Free Cash Flow | -80,282 | -150,077 | -109,900 | -56,539 |
Cash | 124,968 | 230,784 | 85,262 | 284,309 |
Basic Shares | 93,623 | 79,773 | 65,466 | 61,952 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.29 |
2025-03-31 | -$0.35 |
2024-12-31 | -$0.63 |
